CDISC-compliant clinical trial imaging management system with automatic verification and data Transformation: Focusing on tumor response assessment data in clinical trials
Open Access
- 9 April 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Biomedical Informatics
- Vol. 117, 103782
- https://doi.org/10.1016/j.jbi.2021.103782
Abstract
No abstract availableFunding Information
- National Research Foundation of Korea (NRF-2020R1F1A1076604)
This publication has 11 references indexed in Scilit:
- Impact of pseudoprogression and treatment beyond progression on outcome in patients with non-small cell lung cancer treated with immune checkpoint inhibitorsOncoImmunology, 2020
- Radiology workflow for RECIST assessment in clinical trials: Can we reconcile time-efficiency and quality?European Journal of Radiology, 2019
- A Good Practice–Compliant Clinical Trial Imaging Management System for Multicenter Clinical Trials: Development and Validation StudyJMIR Public Health and Surveillance, 2019
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeuticsThe Lancet Oncology, 2017
- S2O – A software tool for integrating research data from general purpose statistic software into electronic data capture systemsBMC Medical Informatics and Decision Making, 2017
- What are biomarkers?Current Opinion in HIV and AIDS, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Evolution and Implementation of the CDISC Study Data Tabulation Model (SDTM)Pharmaceutical Programming, 2008
- Toward a Comprehensive CDISC Submission Data StandardDrug Information Journal, 2007
- Controlled Terminology for Clinical Research: A Collaboration between CDISC and NCI Enterprise Vocabulary ServicesDrug Information Journal, 2007